UK markets closed

Elite Pharmaceuticals, Inc. (ELTP)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.1715+0.0025 (+1.48%)
As of 01:17PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Total revenue
47,318
34,155
32,262
25,381
17,995
Cost of revenue
25,638
17,561
17,467
13,514
10,016
Gross profit
21,680
16,594
14,795
11,867
7,979
Operating expenses
Research development
7,591
6,200
4,051
5,113
5,532
Selling general and administrative
5,794
5,162
4,478
3,336
3,412
Total operating expenses
14,714
12,625
9,725
9,763
10,264
Operating income or loss
6,966
3,969
5,071
2,105
-2,285
Interest expense
701.964
1,113
191.816
259.598
355.874
Total other income/expenses net
-8,674
1,122
1,425
2,299
390.952
Income before tax
-2,386
3,986
6,304
4,145
-2,238
Income tax expense
-17,940
424.028
-1,736
-943.907
2
Income from continuing operations
15,554
3,562
8,898
5,088
-2,240
Net income
15,554
3,562
8,898
5,088
-2,240
Net income available to common shareholders
15,554
3,562
8,898
5,088
-2,240
Basic EPS
0.02
0.00
0.01
0.01
-0.00
Diluted EPS
0.02
0.00
0.01
0.00
-0.00
Basic average shares
1,013,988
1,012,911
1,010,608
942,998
832,327
Diluted average shares
1,015,502
1,012,911
1,010,608
942,998
993,261